| 标题 |
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lung cancer (Amsterdam, Netherlands) 作者:Peters S; Danson S; Ejedepang D; Dafni U; Hasan B; et al 出版日期:2021/11/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)